Survey Stent-Save a Life! (SSL) / SOLACI | Procedural variation in the performance of Primary PCI

These last decades, primary percutaneous coronary intervention (PCI) has improved STEMI patient prognosis. However, its penetration varies across to regions and countries. 

Survey Stent-Save a Life!

As part of the initiative Stent-Save a Life! (SSL), SOLACI is publishing this electronic survey to assess the use of primary PCI throughout different countries based on the assumption that there is significant variation between the different regions and nations. This survey is to be answered only by interventional cardiologists. 

It consists of 12 specific questions that should not take longer than 7 minutes to answer. Help us answer this survey to obtain representative results as regards Latin America. It is vital to be able to count on reliable data in order to keep advancing our daily practice and, in turn, patient quality of life. 

We invite all interventional cardiologists to answer these questions before October 30, 2022. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

SOLACI-CACI 2024 – Presentations day 3

Discover the highlights of the third day of activities of  SOLACI-CACI 2024 Congress, held from August 7 to 9 at the Hilton Hotel in Buenos Aires, Argentina. Dr....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...